Botulinum toxin type A: all 754 studies that test it

Page 2 of 8. Open to participants first (87), then studies with results posted, then the rest; newest registration first within each.

• Botox for the Treatment of Recurrent Chronic Exertional Compartment SyndromeTerminatedNCT05006417Phase 4Results posted
• A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Platysma ProminenceCompletedNCT04994535Phase 3Results posted
• A Comparative Study to Evaluate the Effects and Mechanism of Action of Dysport®, Botox® and Xeomin® in the Extensor Digitorum Brevis Model in Healthy Adult Male ParticipantsCompletedNCT04970407Phase 1Results posted
• Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal PancreatectomyTerminatedNCT04965311Phase 2Results posted
• A Study To Assess the Safety and Effects of OnabotulinumtoxinA (BOTOX) Intramuscular Injection in Adult Participants With Moderate to Severe Platysma ProminenceCompletedNCT04949399Phase 3Results posted
• A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.CompletedNCT04936542Phase 4Results posted
• Combination Facial Aesthetic Treatment in MillennialsCompletedNCT04755595Phase 2Results posted
• Study to Evaluate Subject Satisfaction With Facial Appearance and Impact of Combined Facial TreatmentCompletedNCT04609020Phase 4Results posted
• Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Upper Facial LinesCompletedNCT04259086Phase 2Results posted
• Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in CombinationCompletedNCT04247074Phase 3Results posted
• Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal LinesCompletedNCT04225260Phase 3Results posted
• Sling vs Botox for Mixed IncontinenceCompletedNCT04171531Phase 3Results posted
• Is 10 Injections of Bladder Botox Less Painful Than 20 Injections?CompletedNCT04124939Phase 4Results posted
• BOTOX® Treatment for Adults With a Wide Lower Face Due to Masseter Muscle ProminenceCompletedNCT04073303Phase 3Results posted
• Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study III (BLESSIII)CompletedNCT03985982Phase 3Results posted
• Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar LinesCompletedNCT03960957Phase 3Results posted
• Botox for the Treatment of Chronic Exertional Compartment SyndromeTerminatedNCT03922139Phase 1/2Results posted
• BOTOX® for the Treatment of Platysma ProminenceCompletedNCT03915067Phase 2Results posted
• ET-01 in Subjects With Lateral Canthal Lines, LCL-209CompletedNCT03912805Phase 2Results posted
• Efficacy and Safety of Increasing Doses of DaxibotulinumtoxinA for Injection (DAXI for Injection) in the Treatment of Moderate or Severe Lateral Canthal LinesCompletedNCT03911102Phase 2Results posted
• BOTOX® (onabotulinumtoxinA) Treatment of Masseter Muscle ProminenceCompletedNCT03861936Phase 2Results posted
• ET-01 in Subjects With Lateral Canthal Lines, LCL-208CompletedNCT03839693Phase 2Results posted
• Efficacy and Safety of DaxibotulinumtoxinA (DAXI) for Injection for Treatment of Forehead Lines (Frontalis)CompletedNCT03786770Phase 2Results posted
• Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)CompletedNCT03779841Phase 2Results posted
• Subject Satisfaction With AbobutulinumtoxinA TreatmentCompletedNCT03687736Phase 4Results posted
• Dysport in Post-Surgical NeuralgiaCompletedNCT03663101Phase 2Results posted
• ET-01 in Subjects With Lateral Canthal Lines, LCL-207CompletedNCT03655691Phase 2Results posted
• The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's PhenomenonTerminatedNCT03639766Phase 4Results posted
• Dysport in Vulvodynia Phase II StudyTerminatedNCT03598777Phase 2Results posted
• Dysport in Hallux Abducto Valgus (HAV) Phase IIaCompletedNCT03569098Phase 2Results posted
• OnabotulinumtoxinA Bladder Injection StudyTerminatedNCT03523091Phase 4Results posted
• Assessment of Gait After Dysport TreatmentCompletedNCT03501043Phase 4Results posted
• Effect of Dysport Injections on Energy Expenditure and Walking Efficiency in Children With Cerebral PalsyCompletedNCT03469999Phase 3Results posted
• (Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers ExistCompletedNCT03381261Phase 4Results posted
• Functional Effects of Botox on the Brain Using MRS and fMRICompletedNCT03373162Phase 4Results posted
• The Movement of Botulinum Toxin Through the Lateral Gastrocnemius Muscle in Humans: An Expanded ExaminationTerminatedNCT03367429Phase 4Results posted
• ET-01 in Subjects With Lateral Canthal LinesCompletedNCT03326856Phase 2Results posted
• BOTOX® Intravesical Instillation in Participants With Overactive Bladder and Urinary IncontinenceCompletedNCT03320850Phase 2Results posted
• A Phase III Study to Evaluate the Efficacy and Safety of GSK1358820 in Subjects With Post-stroke Upper Limb SpasticityCompletedNCT03261167Phase 3Results posted
• Botulinum Toxin Versus Placebo Injections to Temporalis and Masseter MusclesCompletedNCT03223298Phase 3Results posted
• Phase 2 DaxibotulinumtoxinA for Injection for the Management of Plantar FasciitisCompletedNCT03137407Phase 2Results posted
• Botulinum Toxin for Erectile DysfunctionCompletedNCT03102762Phase 2/3Results posted
• A Study of the Efficacy of Botox in the Treatment of Social Anxiety DisorderTerminatedNCT03078270Phase 4Results posted
• Effectiveness of Onabotulinumtoxin A (Botox) in Pediatric Patients Experiencing Migraines: A Study in the Pediatric Pain PopulationCompletedNCT03055767Phase 2Results posted
• Evaluation of an Alternative Injection Paradigm for OnabotulinumtoxinA (BOTOX®) in the Treatment of Overactive Bladder in Patients With Urinary IncontinenceCompletedNCT03052764Phase 4Results posted
• Comparison of Three Botulinum Neuromodulators for Management of Facial SynkinesisCompletedNCT03048383Phase 4Results posted
• Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesCompletedNCT03014635Phase 3Results posted
• Efficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesCompletedNCT03014622Phase 3Results posted
• Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar LinesCompletedNCT03004248Phase 3Results posted
• Study to Evaluate Effects of DYSPORT® Injected in Lower and Upper Limb Combined With Guided Self-Rehabilitation Contract (GSC)CompletedNCT02969356Phase 4Results posted
• Botulinum Toxin Type A in Preventing Complications After Surgery in Patients With Esophageal CancerCompletedNCT02965976Phase 2Results posted
• Botulinum Toxin A Single Blind Split-Face Randomized Pilot StudyCompletedNCT02907268Phase 2Results posted
• Injecting Botulinum Toxin A Underneath the Skin to Treat Spinal Cord Pain in Patients With Spinal Cord InjuryTerminatedNCT02736890Phase 2Results posted
• The SLIM Study: Sling and Botox® Injection for Mixed Urinary IncontinenceCompletedNCT02678377Phase 4Results posted
• Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study IICompletedNCT02677805Phase 3Results posted
• Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study ICompletedNCT02677298Phase 3Results posted
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 2TerminatedNCT02660359Phase 3Results posted
• Dysport® Treatment of Urinary Incontinence in Adults Subjects With Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Injury or Multiple Sclerosis - Study 1TerminatedNCT02660138Phase 3Results posted
• Itch Relieving Effect of Botox: a Study in Healthy SubjectsCompletedNCT02639052Phase 1/2Results posted
• Intracavernosal Injection of Botulinum Toxin Type A in the Treatment of Vascular Erectile DysfunctionCompletedNCT02584686Phase 1Results posted
• Temporary Autonomic Blockade to Prevent Atrial Fibrillation After Cardiac SurgeryCompletedNCT02498769Phase 1/2Results posted
• Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar LinesCompletedNCT02493946Phase 3Results posted
• Clinical Trial To Evaluate ANT-1207 In Participants With Primary Axillary HyperhidrosisCompletedNCT02479139Phase 2Results posted
• Dysport in the Treatment of Glabellar Lines in Chinese SubjectsCompletedNCT02450526Phase 3Results posted
• Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Tremor: A Customized ApproachCompletedNCT02419313Phase 2Results posted
• Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar LinesCompletedNCT02353871Phase 3Results posted
• Prospective, Multi-Center Evaluation of the Efficacy of Peripheral Trigger Decompression Surgery for Migraine HeadachesCompletedNCT02351544Not applicableResults posted
• A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV-002CompletedNCT02334436Phase 3Results posted
• A Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001CompletedNCT02334423Phase 3Results posted
• Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity ProgressionCompletedNCT02321436Phase 4Results posted
• A Safety and Efficacy Study of OnabotulinumtoxinA in Upper Facial RhytidesCompletedNCT02261493Phase 3Results posted
• A Safety and Efficacy Study of OnabotulinumtoxinA in Forehead and Glabellar Facial RhytidesCompletedNCT02261467Phase 3Results posted
• Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip RepairCompletedNCT02247193Phase 1/2Results posted
• BOTOX® Efficacy and Safety in the Treatment of Knee OsteoarthritisCompletedNCT02230956Phase 2Results posted
• Investigation of Efficacy of Botulinum Toxin A (Dysport) in Chronic Low Back PainTerminatedNCT02221648Phase 2Results posted
• Botulinum Toxin A to Treat Arm TremorCompletedNCT02207946Phase 2Results posted
• BOTOX® in the Treatment of Crow's Feet Lines in ChinaCompletedNCT02195687Phase 3Results posted
• Efficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in AdultsCompletedNCT02191579Phase 4Results posted
• Treatment of Chronic Post-Traumatic Headache With OnabotulinumtoxinATerminatedNCT02160535Phase 3Results posted
• Effects of Botox in Obstructed Defecation SyndromeTerminatedNCT02160288Phase 2Results posted
• A Safety and Efficacy Study of BOTOX® in Korean Adults With Chronic MigraineCompletedNCT02147561Phase 4Results posted
• OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb SpasticityTerminatedNCT02145676Phase 3Results posted
• OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult FemalesCompletedNCT02116361Phase 2Results posted
• Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's HandCompletedNCT02107261Phase 2Results posted
• Efficacy And Safety Of Dysport In The Treatment Of Upper Limb Spasticity In ChildrenCompletedNCT02106351Phase 3Results posted
• OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Overactive Bladder in Pediatric Patients (12 to 17)TerminatedNCT02097121Phase 3Results posted
• The Treatment of Glabellar Frown LinesCompletedNCT02096081Phase 4Results posted
• Clinical Study to Investigate the Efficacy and Safety of Two Dose Levels of NT 201 Versus Placebo in Treating Chronic Troublesome Sialorrhea in Various Neurological ConditionsCompletedNCT02091739Phase 3Results posted
• Incobotulinum Toxin for the Treatment of Trigeminal NeuralgiaTerminatedNCT02088632Phase 2Results posted
• BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel SyndromeCompletedNCT02070302Phase 2Results posted
• Botulinum Toxin for the Management of Chronic OrchialgiaCompletedNCT02058836Phase 2Results posted
• The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon FracturesTerminatedNCT02051933Not applicableResults posted
• Duration of Benefit for OnabotulinumtoxinA in Treatment of Chronic MigraineCompletedNCT02037425Phase 4Results posted
• Botulinum Toxin Type A (BOTOX®) Treatment of Masseter Muscle HypertrophyCompletedNCT02010775Phase 2Results posted
• Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral PalsyCompletedNCT02002884Phase 3Results posted
• Investigation of Efficacy of incobotulinumtoxinA (Xeomin) in Relieving Symptoms of Restless Leg Syndrome.CompletedNCT01931878Phase 2Results posted
• IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or RadiationTerminatedNCT01931865Phase 2Results posted
• Dysport for the Treatment of OMDCompletedNCT01921270Phase 1/2Results posted
• A Safety and Efficacy Study of OnabotulinumtoxinA in Premature EjaculationTerminatedNCT01917006Phase 2Results posted
• Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral PalsyCompletedNCT01905683Phase 3Results posted

← Botulinum toxin type A overview